RAFFA WEALTH MANAGEMENT, LLC’s iTeos Therapeutics ITOS Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52	Closed	-$518	–	1201
2025 Q2	$518	Hold	52	–	–	﹤0.01%	990
2025 Q1	$310	Hold	52	–	–	﹤0.01%	1014
2024 Q4	$399	Hold	52	–	–	﹤0.01%	1037
2024 Q3	$531	Hold	52	–	–	﹤0.01%	980
2024 Q2	$772	Sell	52 -44	-46%	-$630	﹤0.01%	966
2024 Q1	$1.31K	Hold	96	–	–	﹤0.01%	821
2023 Q4	$1.05K	Buy	+96	New	+$952	﹤0.01%	807

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's ITOS Position: Q3 2025 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 52 shares — an estimated $518 sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in ITOS in Q4 2023 and held it in 7 quarters. The position peaked at $1.31K in Q1 2024. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 52 iTeos Therapeutics shares in Q3 2025, an estimated $518.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in iTeos Therapeutics in Q4 2023 and held it in 7 quarters.
RAFFA WEALTH MANAGEMENT, LLC's iTeos Therapeutics position peaked at $1.31K in Q1 2024.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q3 2025, filed 27 Jul 2026.